<DOC>
	<DOCNO>NCT01110564</DOCNO>
	<brief_summary>The primary objective non-interventional study evaluate daily symptom variability COPD patient . The secondary objective ; evaluate effect COPD symptom morning activity patient , determine therapeutic expectation patient physician COPD , determine frequent non-drug approach recommend order prevent COPD exacerbation , define COPD patient profile below-mentioned issue : Demographic characteristic , Disease characteristic , Concomitant diseases implement drug treatment . All patient , apply study physician fulfill patient selection criterion patient enrolment period , include . Patients , provide follow measure include study : To apply physician outpatient treatment reason , Age 45 year , diagnose COPD , smoker use smoker ( &gt; 10 package year ) , give consent use medical data . The patient exhibit follow exclusion criterion exclude study : COPD exacerbation still on-going experience last 3 month ( Exacerbation define worsen COPD symptom lead antibiotic and/or short-term oral steroid treatment and/or hospitalization admission emergency unit . ) ; Presence lung cancer important respiratory disease bronchiectasis , pulmonary fibrosis , interstitial pulmonary disease , tuberculosis , sarcoidosis ; Participation interventional clinical trial present Enrollment study . In study , patient record visit physician follow-up thereafter .</brief_summary>
	<brief_title>Study Investigate Daily Symptom Variability , Symptom Effects Morning Activities Chronic Obstructive Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>To apply physician outpatient treatment reason ; diagnose COPD smoker use smoker ( &gt; 10 package year ) give consent use medical data COPD exacerbation still ongoing experience last 3 month Presence lung cancer important respiratory disease bronchiectasis , pulmonary fibrosis , interstitial pulmonary disease , tuberculosis , sarcoidosis Participation interventional clinical trial present Enrollment study</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>daily symptom variability</keyword>
	<keyword>effect symptom morning activity</keyword>
</DOC>